Assessment of RNA at SVR4 and Treatment Completion as Alternative Measures of Hepatitis C Cure for People Who Inject Drugs
Hepatitis C virus treatment guidance was updated to include sustained virologic response at 4-weeks post-treatment (SVR4) as an alternative measure of cure for select groups. Among a community-based sample of people who inject drugs receiving an accelerated test-and-treat protocol, results at treatment completion and SVR4 predicted those at 12-week post-treatment.
Authors
- David V. Glidden (ORCID: https://orcid.org/0000-0001-5888-1419)
- Ryan D. Assaf (ORCID: https://orcid.org/0000-0002-6651-1765)
- Claire McDonell (ORCID: https://orcid.org/0009-0005-7116-3346)
- Meghan D. Morris (ORCID: https://orcid.org/0000-0003-2762-2953)
- Brittney Ayala
- Annie F. Luetkemeyer (ORCID: https://orcid.org/0000-0003-0911-1578)
- Jaline Chan
- Jeff McKinney
- Jennifer C Price
Institutions
- University of California, San Francisco (US)
- San Francisco Medical Society (US)
- University of California San Francisco Medical Center (US)
- Universidad Católica de Santa Fe (AR)
- Center for Health and Gender Equity (US)
- Social Action (NG)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1093/ofid/ofaf737
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00